| Information | |
|---|---|
| has gloss | eng: Reversible Inhibition of Sperm Under Guidance (RISUG), formerly referred to as SMA, is the development name of a male contraceptive developed at IIT Kharagpur in India by Dr. Sujoy K Guha. It is currently undergoing Phase III clinical trials in India. It has been patented in India, China, Bangladesh and the United States. |
| lexicalization | eng: Reversible inhibition of sperm under guidance |
| instance of | c/Experimental methods of birth control |
Lexvo © 2008-2025 Gerard de Melo. Contact Legal Information / Imprint